Insmed | Salg



Sales Endring Dato
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Cytokinetics USD 16.93M 16.46M 2024-12
DBV Technologies USD 560K 512K 2024-12
Dynavax Technologies USD 72.03M 8.6M 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
Insmed USD 104.44M 11.02M 2024-12
Novartis USD 13.56B 386M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Insmed Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.